# A Multimodal Imaging Study of Dopamine in Early Psychosis

> **NCT06977308** · PHASE1 · NOT_YET_RECRUITING · sponsor: **New York State Psychiatric Institute** · enrollment: 115 (estimated)

## Conditions studied

- Clinical High Risk for Psychosis (CHR)

## Interventions

- **DRUG:** Methylphenidate (MPH)
- **DRUG:** [11C]raclopride

## Key facts

- **NCT ID:** NCT06977308
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-10-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 115 (ESTIMATED)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06977308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06977308, "A Multimodal Imaging Study of Dopamine in Early Psychosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06977308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*